Centogene N.V. (CNTG) Fundamentals

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
SHARE INFORMATION
Market Cap$ 29,925,120
Shares Outstanding27,081,557
Float12,863,294
Percent Float47.5%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 216,017,470
Latest Fiscal EPS$ -2.34
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions81
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months177,818
Institutional Holdings Percent15.5%
Institutional Sold Previous 3 Months517,749
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 11.09
52 Week Low$ 1.09
52 Week High Change$ -89.58
21 Day Moving Average$ 1.37
21 Day Extended Moving Average$ 1.3555
50 Day Moving Average$ 1.4749
50 Day Extended Moving Average$ 1.5748
200 Day Moving Average$ 3.1264
200 Day Extended Moving Average$ 3.5124
10 Day Average Volume8,866
20 Day Average Volume12,506
30 Day Average Volume21,181
50 Day Average Volume23,912
Alpha-0.032305
Beta-1.1982
Standard Deviation0.207895
R20.113040
7 Day Price Change$ -0.2339
7 Day Percent Change-17.47%
21 Day Price Change$ -0.385
21 Day Percent Change-25.84%
30 Day Price Change$ -0.325
30 Day Percent Change-22.73%
Month to Date Price Change$ -0.355
Month to Date Percent Change-24.32%
Quarter to Date Price Change$ -1.27
Quarter to Date Percent Change-53.38%
180 Day Price Change$ -3.06
180 Day Percent Change-73.44%
200 Day Price Change$ -2.51
200 Day Percent Change-69.39%
Year to Date Price Change$ -4.12
Year to Date Percent Change-78.87%

Centogene N.V. (CNTG) Key Ratios

PROFITABILITY
EBIT Margin-22.3%
EBITDA Margin-10.8%
Pre-Tax Profit Margin-24.9%
Profit Margin Count-53.98%
Gross Margin14.9%
Profit Margin TOT-48.46%
INCOME STATEMENTS
Revenue$ 88,937,191
Revenue Per Share$ 3.2841
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.90
Total Debt To Equity1.30
Int Coverage-29.20
Current Ratio2.50
Leverage Ratio3.30
Quick Ratio2.10
Long Term Debt To Capital0.53
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 37,035,628
Price to Sales0.336475
Price to Free Cash-1.20
PE High Last 5 Years0.00
Price To Book1.00
Price To Cash Flow6.50
PE Low Last 5 Years0.00
Price to Tangible Book0.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.40
Invoice Turnover28.60
Assets Turnover0.30
Return Assets-38.22
Return on Equity-101.45
Return on Capital-57.69

Centogene N.V. (CNTG) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young GmbH Wirtschaftspruefungsgesellschaft
CEOKim Stratton
Emplyoees808
Last AuditUE
CIK0001757097
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSDiagnostic Imaging Centers(621512)
CONTACT INFO
AddressAm Strande 7
Rostock, MV 18055
Websitehttps://www.centogene.com
Facsimile+49 38180113401
Telephone+49 38180113500
Email-


Your Recent History
NASDAQ
CNTG
Centogene ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.